![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: POLR1D |
Gene summary for POLR1D |
![]() |
Gene information | Species | Human | Gene symbol | POLR1D | Gene ID | 51082 |
Gene name | RNA polymerase I and III subunit D | |
Gene Alias | AC19 | |
Cytomap | 13q12.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | A0A087WTY1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51082 | POLR1D | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.50e-03 | 4.54e-01 | -0.0811 |
51082 | POLR1D | HTA11_347_2000001011 | Human | Colorectum | AD | 1.76e-09 | 4.34e-01 | -0.1954 |
51082 | POLR1D | HTA11_1391_2000001011 | Human | Colorectum | AD | 5.85e-08 | 6.58e-01 | -0.059 |
51082 | POLR1D | HTA11_7862_2000001011 | Human | Colorectum | AD | 6.28e-07 | 6.15e-01 | -0.0179 |
51082 | POLR1D | HTA11_866_3004761011 | Human | Colorectum | AD | 6.00e-13 | 6.04e-01 | 0.096 |
51082 | POLR1D | HTA11_8622_2000001021 | Human | Colorectum | SER | 4.40e-05 | 6.66e-01 | 0.0528 |
51082 | POLR1D | HTA11_7696_3000711011 | Human | Colorectum | AD | 5.25e-10 | 5.35e-01 | 0.0674 |
51082 | POLR1D | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.42e-02 | 4.17e-01 | 0.0588 |
51082 | POLR1D | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.04e-14 | 8.11e-01 | 0.294 |
51082 | POLR1D | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.09e-22 | 1.14e+00 | 0.281 |
51082 | POLR1D | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.71e-49 | 1.58e+00 | 0.3859 |
51082 | POLR1D | HTA11_99999973899_84307 | Human | Colorectum | MSS | 7.64e-33 | 2.23e+00 | 0.2585 |
51082 | POLR1D | HTA11_99999974143_84620 | Human | Colorectum | MSS | 4.16e-17 | 7.38e-01 | 0.3005 |
51082 | POLR1D | A015-C-203 | Human | Colorectum | FAP | 3.36e-06 | -7.53e-02 | -0.1294 |
51082 | POLR1D | A002-C-201 | Human | Colorectum | FAP | 2.07e-03 | -1.77e-01 | 0.0324 |
51082 | POLR1D | A001-C-119 | Human | Colorectum | FAP | 1.37e-02 | -2.64e-01 | -0.1557 |
51082 | POLR1D | A001-C-108 | Human | Colorectum | FAP | 2.19e-05 | -1.93e-01 | -0.0272 |
51082 | POLR1D | A002-C-205 | Human | Colorectum | FAP | 3.43e-05 | -1.52e-01 | -0.1236 |
51082 | POLR1D | A015-C-006 | Human | Colorectum | FAP | 1.12e-03 | -1.80e-01 | -0.0994 |
51082 | POLR1D | A015-C-106 | Human | Colorectum | FAP | 2.85e-03 | -1.03e-01 | -0.0511 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0302021 | Esophagus | ESCC | RNA polymerase | 28/4205 | 34/8465 | 8.19e-05 | 3.35e-04 | 1.71e-04 | 28 |
hsa046234 | Esophagus | ESCC | Cytosolic DNA-sensing pathway | 49/4205 | 75/8465 | 4.35e-03 | 1.12e-02 | 5.74e-03 | 49 |
hsa0302031 | Esophagus | ESCC | RNA polymerase | 28/4205 | 34/8465 | 8.19e-05 | 3.35e-04 | 1.71e-04 | 28 |
hsa0462311 | Esophagus | ESCC | Cytosolic DNA-sensing pathway | 49/4205 | 75/8465 | 4.35e-03 | 1.12e-02 | 5.74e-03 | 49 |
hsa03020 | Liver | HCC | RNA polymerase | 24/4020 | 34/8465 | 5.40e-03 | 1.57e-02 | 8.75e-03 | 24 |
hsa030201 | Liver | HCC | RNA polymerase | 24/4020 | 34/8465 | 5.40e-03 | 1.57e-02 | 8.75e-03 | 24 |
hsa030204 | Oral cavity | OSCC | RNA polymerase | 25/3704 | 34/8465 | 4.12e-04 | 1.27e-03 | 6.45e-04 | 25 |
hsa04623 | Oral cavity | OSCC | Cytosolic DNA-sensing pathway | 44/3704 | 75/8465 | 6.44e-03 | 1.51e-02 | 7.68e-03 | 44 |
hsa0302011 | Oral cavity | OSCC | RNA polymerase | 25/3704 | 34/8465 | 4.12e-04 | 1.27e-03 | 6.45e-04 | 25 |
hsa046231 | Oral cavity | OSCC | Cytosolic DNA-sensing pathway | 44/3704 | 75/8465 | 6.44e-03 | 1.51e-02 | 7.68e-03 | 44 |
hsa030202 | Oral cavity | LP | RNA polymerase | 18/2418 | 34/8465 | 2.35e-03 | 1.03e-02 | 6.63e-03 | 18 |
hsa046232 | Oral cavity | LP | Cytosolic DNA-sensing pathway | 31/2418 | 75/8465 | 1.17e-02 | 3.91e-02 | 2.52e-02 | 31 |
hsa030203 | Oral cavity | LP | RNA polymerase | 18/2418 | 34/8465 | 2.35e-03 | 1.03e-02 | 6.63e-03 | 18 |
hsa046233 | Oral cavity | LP | Cytosolic DNA-sensing pathway | 31/2418 | 75/8465 | 1.17e-02 | 3.91e-02 | 2.52e-02 | 31 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
POLR1D | SNV | Missense_Mutation | c.201N>A | p.Phe67Leu | p.F67L | Q9Y2S0 | protein_coding | deleterious(0) | possibly_damaging(0.642) | TCGA-AX-A063-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
POLR1D | SNV | Missense_Mutation | novel | c.97N>A | p.Gly33Ser | p.G33S | Q9Y2S0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
POLR1D | SNV | Missense_Mutation | c.79N>C | p.Glu27Gln | p.E27Q | Q9Y2S0 | protein_coding | deleterious(0.05) | probably_damaging(0.998) | TCGA-B5-A11R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD | |
POLR1D | SNV | Missense_Mutation | novel | c.92C>T | p.Pro31Leu | p.P31L | Q9Y2S0 | protein_coding | deleterious(0.01) | possibly_damaging(0.755) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
POLR1D | SNV | Missense_Mutation | novel | c.244T>G | p.Leu82Val | p.L82V | Q9Y2S0 | protein_coding | tolerated(0.08) | benign(0.278) | TCGA-E6-A1M0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
POLR1D | SNV | Missense_Mutation | c.161N>A | p.Ser54Tyr | p.S54Y | Q9Y2S0 | protein_coding | deleterious(0) | possibly_damaging(0.853) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
POLR1D | SNV | Missense_Mutation | novel | c.277G>T | p.Val93Phe | p.V93F | Q9Y2S0 | protein_coding | tolerated(0.08) | possibly_damaging(0.721) | TCGA-ZP-A9CY-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
POLR1D | SNV | Missense_Mutation | c.209N>G | p.Tyr70Cys | p.Y70C | Q9Y2S0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BR-8363-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
POLR1D | SNV | Missense_Mutation | c.248N>A | p.Arg83His | p.R83H | Q9Y2S0 | protein_coding | deleterious(0.02) | probably_damaging(1) | TCGA-HU-A4G8-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |